ArticlePharmaceuticals (Basel, Switzerland)2026

Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin.

Hirofumi Hanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.